Back to search

Article

Common anti-platelet therapies modulate procoagulant phospholipids in arterial disease

2022-11-04

Abstract excerpt

Enzymatically oxygenated phospholipids (eoxPL) formed by lipoxygenases (LOX) and cyclooxygenase (COX) in platelets and leukocytes are pro-coagulant in multiple model systems. However, their generation in arterial thrombotic disease, and how their levels are modulated by common therapies is unknown. Here, eoxPL were first characterized in isolated platelets and leukocytes from an arterial vascular disease cohort, a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
88a0b973-decc-5513-b3e6-6a2089185ed7
DOI
10.1101/2022.11.03.22280948
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Common anti-platelet therapies modulate procoagulant phospholipids in arterial diseaseDOI 10.1101/2022.11.03.22280948
Select a neighboring publication to make it the new centre.